Sequential intermediate high-dose chemotherapy in the primary treatment of poor risk testicular cancer.
Martin-Luther-University of Halle-Wittenberg, Germany.
H J
HJ
Schmoll
C
C
Bokemeyer
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008297:Male; D012074:Remission Induction; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000628:therapy*
D016179:Granulocyte Colony-Stimulating Factor; D005047:Etoposide; D002945:Cisplatin; D007069:Ifosfamide